Latest Data & Signals Issued

Below are some of the latest signals issued for Imugene Limited

General

Signal Type Signal Value Data
Score 0.000 1 day ( 0 %
Last Price $0.0950 0 %
Performance History
7 Days
$0.0850 $0.0950
11.76%
30 Days
$0.0910 $0.0950
4.40%
12 Mos
$0.0064 $0.0950
1,384.38%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 44.59
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0950 - $0.0950
Trend - 3 mos -26.74 % High Width: 163.28 %
Pred. range - 3 mos $0.0286 - $0.0753 Low -69.89 % - -20.74 %
Volume Direction Sell High Volume: 4,710 · Direction: 0
Pivot Short Sell Very Low Jun 22, 2026 - 2 days
RSI Short Pivot Signal Buy Very Low Jun 22, 2026 - 2 days
Short MA 3 mos Buy Low Jun 17, 2026 - 4 days
Long MA 3 mos Buy Medium Jun 17, 2026 - 4 days
Short/Long MA 3 mos Buy Medium Jun 11, 2026 - 8 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.4
Signal Type Signal Value Importance Data
Trend - 12 mos -15.61 % Very High Width: 728.34 %
Pred. range - 12 mos N/A - $0.272 High -100.00 % - 185.90 %
Short MA 12 mos Buy Very High Jun 17, 2026 - 4 days
Long MA 12 mos Sell Very High Feb 04, 2026 - 96 days
Short/Long MA 12 mos Sell Very High Feb 04, 2026 - 96 days
Pivot Long Sell Low Jun 22, 2026 - 2 days
RSI Long Pivot Signal Buy Low Jun 22, 2026 - 2 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Click to get the best stock tips daily for free!
ABOUT IMUGENE LIMITED
Imugene
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing P...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE